Maya Fayfman
Emory University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Maya Fayfman as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:27 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06054659 · CGM and DFU Healing Post-dischargeEmory University · completed · Diabetic Foot, Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown · principal investigator
- Ph4NCT04416269 · Oral Anti Diabetic Agents in the HospitalEmory University · terminated · Diabetes Mellitus · principal investigator
- Ph4NCT02741687 · Sitagliptin in Non-Diabetic Patients Undergoing General SurgeryEmory University · completed · Hyperglycemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:27 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-Foot-Nav), a randomized controlled trialR01DK139326 · NIDDK · EMORY UNIVERSITY · fiscal years 2025 to 2026 · $552,988 awarded in 2026Same name and institution; not confirmed by an ID
- Use of Non-Insulin Agents in Hospitalized Patients with Type 2 diabetes (T2D)K23DK124647 · NIDDK · EMORY UNIVERSITY · fiscal years 2020 to 2024 · $167,907 awarded in 2024Grant number is on one of their registry trials
- Randomized controlled trial of continuous glucose monitoring compared to point of care glucose testing following hospital discharge on 12-week diabetic foot ulcer healing ratesR03DK137007 · NIDDK · EMORY UNIVERSITY · fiscal years 2023 · $191,700 awarded in 2023Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:27 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial.Diabetes Care · 2022103 citationsRCR 8.9
- A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes.Diabetes Care · 201960 citationsRCR 2.6
- A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial.J Am Med Dir Assoc · 201834 citationsRCR 1.3
- 31 citationsRCR 1.7
- Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy.J Diabetes Complications · 201724 citationsRCR 0.9
- Inflammation and Oxidative Stress in Cardiac Surgery Patients Treated to Intensive Versus Conservative Glucose Targets.J Clin Endocrinol Metab · 201723 citationsRCR 1.1
- Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes.Diabetes Obes Metab · 202220 citationsRCR 1.7
- Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge.Diabetes Obes Metab · 202119 citationsRCR 1.3
- 15 citationsRCR 1.5
- Sitagliptin for prevention of stress hyperglycemia in patients without diabetes undergoing general surgery: A pilot randomized study.J Diabetes Complications · 201814 citationsRCR 0.6